<DOC>
	<DOC>NCT01589133</DOC>
	<brief_summary>The purpose of this study is to assess the consistency of the results of irregular antibody screening with Surgiscreen （investigational reagent) and Serascan Diana 3 (control reagent), and the consistency of the results of irregular antibody screening with investigational reagent on serum and plasma from same patients.</brief_summary>
	<brief_title>Surgiscreen Registration</brief_title>
	<detailed_description />
	<criteria>Serum or plasma samples left after routine clinical testing; Blood sample of the same day, or blood samples stored at 28°C for 3 days after collection, or serum or plasma samples stored at 20°C for those separated 3 days after collection. Samples with severe hemolysis, jaundice or chylelike samples; Small sample size insufficient for completing the testing; Samples not collected and processed upon the requirements of the instructions.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Irregular antibody screening</keyword>
</DOC>